then the stock will down, that is the time to get in.
this is good enough to move the stock pass .35, can it go back to $1.7, not sure, exact same as sphs!
Sentiment: Strong Buy
I will join you with my 1.1 million shares.
I am in NY, I know some very good lawyer here.
As of Sept. 18, there is 15,365,663 Series C Warrants outstanding according to sec-8k, each c warrants cash value $2.55, so need about 50 shares to cover the convert (5 cent per share), that mean 15 mx50=750million shares if all the c warrants convert to common share at current price 5 cents, if share price go down, then the outstanding share eventually will more than 10b? do i get it right?
Since the stock hit .28, there more than 100m shares be traded, i think they will convert about 100m shares to get 30m dollar cash this time, then the total outstanding share will be 200m, total cash will be .45 cents per share.
Run could star tomorrow afternoon 3pm
Nothing is 100% certain, even lottery have possibility.
In April 2014, the Company completed enrollment in our Phase I/II clinical trial in chronic spinal cord injury. The multi-national, open-label, Phase I/II trial is evaluating both safety and preliminary efficacy of our proprietary HuCNS-SC product candidate as a treatment for chronic spinal cord injury. The trial enrolled twelve subjects with chest-level injury to the spinal cord: seven patients with complete paralysis, no motor or sensory function below the point of injury, classified as complete (AIS A), according to the American Spinal Injury Association Impairment Scale, and five patients with no motor function and limited sensory function below the point of injury classified as incomplete (AIS B). Dr. Armin Curt, the principal investigator for the trial at Balgrist Hospital, Zurich will present a clinical update on this study on Saturday May 17, at the Annual Meeting of the American Spinal Injury Association, to be held in San Antonio, Texas.